$MRMD News

MariMed Inc. (MRMD) Q1 2026 Earnings Call Transcript

MariMed Q1 2026 Earnings Call: Complete Transcript

MariMed Inc. 2026 Q1 - Results - Earnings Call Presentation

MariMed Q1 Adj. EPS $(0.01), Inline, Sales $39.481M Beat $38.750M Estimate

Myomo, Inc. (MYO) Reports Q1 Loss, Beats Revenue Estimates

MariMed Announces First Quarter 2026 Earnings Date

MariMed Inc. 2025 Q4 - Results - Earnings Call Presentation

MariMed Inc (MRMD) Q4 2025 Earnings Call Highlights: Steady Revenue Growth Amid Market Challenges

MariMed Inc. (MRMD) Q4 2025 Earnings Call Transcript

MariMed Reports Fourth Quarter and Full Year 2025 Earnings

MariMed Q4 Adj. EPS $0.01 Beats $(0.01) Estimate, Sales $41.650M Beat $40.600M Estimate.

An Overview of MariMed's Earnings

MariMed Extends Series B Preferred Stock Obligation Through 2031, Strengthening Capital Structure

MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date

MariMed’s Betty’s Eddies™ Introduces New Limited-Edition Valentine’s Seasonal, Berry In Love Betty

MariMed Launches Hemp-Derived THC Products Under its Vibations™ Brand in Rhode Island

Veterans Healing Journey Becomes Soundtrack of Thrive Dispensaries

GreenSpace Appoints Industry Veteran Joe Khoury as Chief Digital Officer to Accelerate Next-Stage Growth

MariMed’s Betty’s Eddies™ Introduces New Limited-Edition Winter Seasonal Cranberry Orange Fruit Chew, Bundle Up Betty’s

MariMed Inc (MRMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Industry Challenges